A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales
Asempa, Tomefa E., PharmD, Kuti, Joseph L., PharmD, FIDP, Seroogy, Julie D., BS, Komirenko, Allison S., PharmD, Nicolau, David P., PharmD, FCCP, FIDSA
Published in Clinical therapeutics (01.08.2019)
Published in Clinical therapeutics (01.08.2019)
Get full text
Journal Article
A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function
Komirenko, Allison S, Riddle, Valerie, Gibbons, Jacqueline A, Van Wart, Scott, Seroogy, Julie D
Published in Antimicrobial agents and chemotherapy (01.12.2018)
Published in Antimicrobial agents and chemotherapy (01.12.2018)
Get full text
Journal Article
Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug–Drug Interaction Studies in Healthy Participants
Perera, Vidya, Gretler, Daniel D., Seroogy, Julie D., Chiang, Manting, Palmisano, Maria, Florea, Victoria
Published in Clinical pharmacology in drug development (01.12.2023)
Published in Clinical pharmacology in drug development (01.12.2023)
Get full text
Journal Article
Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
Trang, Michael, Seroogy, Julie D, Van Wart, Scott A, Bhavnani, Sujata M, Kim, Aryun, Gibbons, Jacqueline A, Ambrose, Paul G, Rubino, Christopher M
Published in Antimicrobial agents and chemotherapy (01.04.2019)
Published in Antimicrobial agents and chemotherapy (01.04.2019)
Get full text
Journal Article
Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection
Asempa, Tomefa E, Kuti, Joseph L, Seroogy, Julie D, Komirenko, Allison S, Nicolau, David P
Published in Antimicrobial agents and chemotherapy (01.10.2019)
Published in Antimicrobial agents and chemotherapy (01.10.2019)
Get full text
Journal Article
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
Chang, Peter, Perera, Vidya, Salinger, David H., Merali, Samira, Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D., Gretler, Daniel D., Sehnert, Amy J., Palmisano, Maria, Roy, Amit
Published in CPT: pharmacometrics and systems pharmacology (13.08.2024)
Published in CPT: pharmacometrics and systems pharmacology (13.08.2024)
Get full text
Journal Article
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathy
Merali, Samira, Salinger, David H, Palmisano, Maria, Sehnert, Amy J, Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D, Gretler, Daniel D, Roy, Amit, Perera, Vidya
Published in CPT: pharmacometrics and systems pharmacology (02.05.2024)
Published in CPT: pharmacometrics and systems pharmacology (02.05.2024)
Get full text
Journal Article
Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study
Patel, Jignes H, Churchwell, Marianne D, Seroogy, Julie D, Barriere, Steven L, Grio, Maricor, Mueller, Bruce
Published in International journal of artificial organs (01.10.2009)
Published in International journal of artificial organs (01.10.2009)
Get more information
Journal Article
1400. Mass Balance, Metabolism, and Excretion of [14C]-Plazomicin in Healthy Human Subjects
Choi, Taylor, Seroogy, Julie D, Sanghvi, Mitesh, Dhuria, Shyeilla V
Published in Open forum infectious diseases (26.11.2018)
Published in Open forum infectious diseases (26.11.2018)
Get full text
Journal Article
Population Pharmacokinetics (PPK) of Plazomicin and Use of Therapeutic Drug Management (TDM) in Critically Ill Patients
Wart, Scott A. Van, Seroogy, Julie D., Trang, Michael, Connolly, Lynn E., Rubino, Christopher M., Jubb, Adrian M., Bhavnani, Sujata M., Riddle, Valerie, Mizuno, Tomoyuki, Vinks, Alexander A., Forrest, Alan
Published in Open forum infectious diseases (01.12.2016)
Published in Open forum infectious diseases (01.12.2016)
Get full text
Journal Article
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF
SEROOGY, Julie D, HUSFELD, Craig O, WRAY, Jonathan W, JENKINS, Thomas E
Year of Publication 07.12.2022
Get full text
Year of Publication 07.12.2022
Patent
Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
Jenkins, Thomas E, Wray, Jonathan W, Seroogy, Julie D, Husfeld, Craig O
Year of Publication 02.08.2022
Get full text
Year of Publication 02.08.2022
Patent
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF
Jenkins, Thomas E, Wray, Jonathan W, Seroogy, Julie D, Husfeld, Craig O
Year of Publication 09.06.2022
Get full text
Year of Publication 09.06.2022
Patent
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF
SEROOGY, Julie D, HUSFELD, Craig O, WRAY, Jonathan W, JENKINS, Thomas E
Year of Publication 12.01.2022
Get full text
Year of Publication 12.01.2022
Patent
Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
Jenkins, Thomas E, Wray, Jonathan W, Seroogy, Julie D, Husfeld, Craig O
Year of Publication 23.11.2021
Get full text
Year of Publication 23.11.2021
Patent
COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF
SEROOGY, Julie D, HUSFELD, Craig O, WRAY, Jonathan W, JENKINS, Thomas E
Year of Publication 10.09.2020
Get full text
Year of Publication 10.09.2020
Patent
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Jenkins, Thomas E, Wray, Jonathan W, Seroogy, Julie D, Husfeld, Craig O
Year of Publication 13.08.2020
Get full text
Year of Publication 13.08.2020
Patent